# FDA recall D-0061-2023

> **Par Formulations Private Limited** · Class II · drug recall initiated 2022-11-10.

## Product

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0061-2023
- **Recalling firm:** Par Formulations Private Limited
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-11-10
- **Report date:** 2022-11-23
- **Termination date:** 2023-08-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chennai, N/A, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0061-2023

## Citation

> AI Analytics. FDA recall D-0061-2023. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0061-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*